NIH Grants $62M for Epigenomics Roadmap Program | GenomeWeb

NEW YORK (GenomeWeb News) – The National Institutes of Health will pump $62 million into more than twenty studies focused on using epigenomics to understand how environmental factors, aging, diet, and stress influence human disease.

Funded over five years under the NIH Roadmap for Medical Research's Epigenomics Program, scientists will use these funds to study the epigenome in a wide range of diseases and conditions, including tumor development, autism, hardening of the arteries, glaucoma, aging, asthma, and abnormal growth and development.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.

Sponsored by

This webinar will discuss a project that sought to understand the parent-of-origin epigenetic mechanisms that regulate seed development in plants, with a particular emphasis on differentiating the maternal or paternal origin of epigenetics marks.